HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Travis Selected Research

Gingipain Cysteine Endopeptidases

6/2009Gingipain enzymes from Porphyromonas gingivalis preferentially bind immobilized extracellular proteins: a mechanism favouring colonization?
5/2008Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells.
8/2006Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II).
10/2003Proteolysis of ICAM-1 on human oral epithelial cells by gingipains.
10/2001Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.
7/2001Inhibition of distant caspase homologues by natural caspase inhibitors.
2/2001Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo.
1/2001Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis.
9/2000Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Travis Research Topics

Disease

8Periodontal Diseases (Periodontal Disease)
06/2009 - 01/2000
8Periodontitis
08/2006 - 01/2000
2Chronic Periodontitis
10/2001 - 01/2001
2Infections
07/2001 - 03/2000
1Ulcer
01/2020
1Diabetic Foot
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Respiratory Insufficiency (Respiratory Failure)
03/2009
1Cowpox
07/2001
1Cardiovascular Diseases (Cardiovascular Disease)
06/2001
1Astrocytoma (Pilocytic Astrocytoma)
04/2001
1Gingivitis
03/2001
1Inflammation (Inflammations)
02/2001
1Alzheimer Disease (Alzheimer's Disease)
10/2000
1Bone Resorption
10/2000

Drug/Important Bio-Agent (IBA)

9Gingipain Cysteine EndopeptidasesIBA
06/2009 - 09/2000
8Peptide Hydrolases (Proteases)FDA Link
06/2009 - 01/2000
6Cysteine Proteases (Cysteine Protease)IBA
05/2008 - 09/2000
4Virulence Factors (Pathogenicity Factors)IBA
05/2008 - 10/2001
3Arginine (L-Arginine)FDA Link
08/2001 - 09/2000
3ThrombinFDA Link
06/2001 - 10/2000
3EnzymesIBA
03/2001 - 01/2000
2CytokinesIBA
07/2001 - 04/2001
2ProstaglandinsIBA
06/2001 - 01/2001
2Interleukin-1 (Interleukin 1)IBA
06/2001 - 01/2001
116S Ribosomal RNAIBA
01/2020
1Hemagglutinins (Hemagglutinin)IBA
06/2009
1ChlorhexidineIBA
08/2006
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2003
1Anti-Bacterial Agents (Antibiotics)IBA
10/2001
1Cysteine Proteinase InhibitorsIBA
10/2001
1TetracyclinesIBA
10/2001
1SerpinsIBA
07/2001
1aspartyllysineIBA
07/2001
1Complement System Proteins (Complement)IBA
07/2001
1Oncostatin MIBA
04/2001
1Peptides (Polypeptides)IBA
04/2001
1HistatinsIBA
03/2001
1OligopeptidesIBA
01/2001
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2001
1Factor IXa (Coagulation Factor IXa)IBA
01/2001
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2001
1alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA
10/2000
1BradykininIBA
10/2000
1KininsIBA
10/2000
1Kallikreins (Kallikrein)IBA
10/2000
1Indicators and Reagents (Reagents)IBA
10/2000

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
03/2009